Abiopharma

🔍 Subotovsky Santiago (Director)

Company: Zoom Communications, Inc. (ZM)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 3,583 shares of Class A Common Stock (Direct)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 141,191.00 | transaction_form_type: 4
• Sold 3,583 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-10 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 3,012 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,012.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Holds 2,928,046 shares of Class B Common Stock (Derivative)
  Date: 2026-06-10 | Code: H | shares_owned_after: 2,928,046.00 | Footnotes: F3, F3, F3, F4

Footnotes:

• F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer's Class A Common Stock.
• F2: The reporting person received an award of restricted stock units, 100% of which will vest on the first anniversary date of the grant (or, if sooner, the day immediately preceding the next annual meeting that occurs following the grant date).
• F3: Each share of Class B Common Stock is convertible at the option of Emergence Capital Partners III, L.P. ("Emergence") and EZP Opportunity, L.P. ("EZP"), as applicable, into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock held by Emergence and EZP, as applicable, will automatically convert into one share of Class A Common Stock upon any transfer by Emergence and EZP, as applicable, except certain "Permitted Transfers" described in the Issuer's certificate of incorporation. All outstanding shares of Class B Common Stock will convert into shares of Class A Common Stock upon the earliest of (i) six months following the death or incapacity of Mr. Yuan, (ii) six months following the date that Mr. Yuan ceases providing services to the Issuer, (iii) the date specified by the holders of a majority of the shares of Class B Common Stock, and (iv) the 15-year anniversary of the closing of the Issuer's initial public offering.
• F4: Shares held directly by Emergence. The sole general partner of Emergence is Emergence Equity Partners III, L.P. ("EEP III"), and the sole general partner of EEP III is Emergence GP Partners, LLC ("EGP"). The Reporting Person is a member of EEP III. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by Emergence, except to the extent, if any, of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 or any other purpose.